Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer? | Zendy

Aamna Hassan | Zendy; Saima Riaz | Zendy; Humayun Bashir | Zendy; M. Nawaz | Zendy; Raza Hussain | Zendy

Open Access

Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer?

Author(s) -

Aamna Hassan,

Saima Riaz,

Humayun Bashir,

M. Nawaz,

Raza Hussain

Publication year - 2016

Publication title -

european thyroid journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.23

H-Index - 10

eISSN - 2235-0802

pISSN - 2235-0640

DOI - 10.1159/000448920

Subject(s) - medicine , thyroid cancer , nuclear medicine , thyroglobulin , thyroid , papillary thyroid cancer , refractory (planetary science) , retrospective cohort study , predictive value , physics , astrobiology

The aim of this study was to compare the TNM staging system and the American Thyroid Association (ATA) recurrence risk classification in predicting radioiodine refractory disease (RRD) in differentiated thyroid cancer (DTC) and to analyze the correlation of stimulated thyroglobulin (Tg) levels and rate of Tg elevation with the standardized uptake value on 18 F-fludeoxyglucose (FDG) PET/CT scan.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research